RECURRENT LUNG CANCER
Clinical trials for RECURRENT LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LUNG CANCER trials appear
Sign up with your email to follow new studies for RECURRENT LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets hard-to-treat cancers with KRAS and BRAF mutations
Disease control Recruiting nowThis early-phase study tests an oral drug called S241656 in adults with advanced cancers that have certain gene changes (KRAS, BRAF, and others). The drug is given alone or with other cancer treatments. The goal is to find safe doses and see if the drug shrinks tumors. About 554 …
Matched conditions: RECURRENT LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Tiny radiation implants take aim at returning lung tumors
Disease control Recruiting nowThis early-stage trial tests a new device that delivers a special type of radiation directly into lung tumors that have come back. The goal is to see if the procedure is safe and possible to do. About 10 adults with recurrent lung cancer will take part.
Matched conditions: RECURRENT LUNG CANCER
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC